Alteryx, Inc.

Q3 2023 ARR was $914 million, up 21% year over year, and revenue was $232 million, up 8% year over year. Non-GAAP operating income was $36 million, which management said was $30 million above the high end of guidance. Kevin Rubin said Q3 ARR was $9 million above the high end of the guided range, or $15 million above after excluding a roughly $6 million FX headwind. For Q4 2023, Alteryx guided ARR to $942 million to $948 million, revenue to $334 million to $340 million, non-GAAP operating income to $112 million to $118 million, and non-GAAP EPS to $1.10 to $1.17. For full-year 2023, the company raised revenue guidance to $953 million to $959 million, non-GAAP operating profit to $100 million to $106 million, and non-GAAP EPS to $0.94 to $1.01.

Mark Anderson framed Q3 as a solid quarter driven by better execution and growing customer commitment to the platform. He emphasized the company’s enterprise strategy, cloud-connected analytics platform, and GenAI investments under AiDIN, saying Alteryx is positioned as the orchestration layer in a fragmented data ecosystem. His tone was confident but still measured, repeatedly noting that the team has more work ahead and that guidance remains prudent given macro uncertainty.

Kevin Rubin focused on how improved execution and cost control flowed through the financials. He highlighted that revenue beat guidance by $20 million and non-GAAP operating income beat by $30 million, with lower incremental spend and process optimization helping margin leverage. He also said sales and marketing expense fell by more than five points as a percentage of revenue versus Q3 last year, and noted the company expects to enter 2024 with a leaner cost structure, although some cost actions still have trailing cash impact.

Analysts pressed on whether Q4 guidance was too conservative given the Q3 upside, and management said it was intentionally prudent because of macro uncertainty and the need to prove the execution improvements over time. They also asked about the burstable ELA model, and Paula Hansen said Q3 ELA sales more than doubled year over year and Q4 should be an even bigger upsell opportunity because the company is lapping its biggest ELA quarter from last year. On sales execution, management said better forecasting discipline, tighter qualification, and enablement changes helped, while about half of the Q2 non-renewal deals that slipped had returned in Q3.